<i>Pneumocystis</i> and Severe Acute Respiratory Syndrome Coronavirus 2 Coinfection: A Case Report and Review of an Emerging Diagnostic Dilemma
Carlos Rubiano, Kathleen Tompkins, Subhashini A. Sellers, Brian Bramson, Joseph J. Eron, Jonathan B. Parr, Asher J Schranz
Abstract
Abstract We present a case of a critically ill patient with coronavirus disease 2019 (COVID-19) found to have acquired immune deficiency syndrome and Pneumocystis jirovecii pneumonia (PCP). Coronavirus disease 2019 and PCP co-occurrence is increasingly reported and may complicate diagnostic and therapeutic strategies. Patients with severe COVID-19 should be screened for underlying immunocompromise and coinfections should be considered.
Topics & Concepts
MedicineCoinfectionPneumoniaCoronavirusCoronavirus disease 2019 (COVID-19)Pneumocystis jiroveciiIntensive care medicineImmunologyDiseaseInternal medicineHuman immunodeficiency virus (HIV)Infectious disease (medical specialty)Pneumocystis jirovecii pneumonia detection and treatmentPneumonia and Respiratory InfectionsDrug-Induced Adverse Reactions